Xingqi Pharmaceutical announced that on July 28, 2026, the company first repurchased 460,190 shares through centralized bidding transactions, accounting for 0.13% of the total share capital. The lowest transaction price was 39.54 yuan/share, the highest price was 40.15 yuan/share, and the total payment amount was 18.3 million yuan. This repurchase complies with the requirements of the plan and regulations, and will continue to be implemented and promptly disclosed within the period.

According to Xingqi Pharmaceutical's announcement, the company first repurchased 460,190 shares through centralized bidding transactions on July 28, 2026, accounting for 0.13% of the total share capital. The lowest transaction price was 39.54 yuan/share, the highest price was 40.15 yuan/share, and the total payment amount was 18.3 million yuan. This repurchase complies with the requirements of the plan and regulations, and will continue to be implemented and promptly disclosed within the period.